[1] Precision Oncology Overview - Remon, J. and Dienstmann, R., 2018. Precision oncology: separating the wheat from the chaff. ESMO open, 3(6),
https://doi.org/10.1136/esmoopen-2018-000446
[2] Oncology Treatment Options Overview - Blinman, P., King, M., Norman, R., Viney, R. and Stockler, M.R., 2012. Preferences for cancer treatments: an overview of methods and applications in oncology. Annals of oncology, 23(5), pp.1104-1110.
https://doi.org/10.1093/annonc/mdr559
[3] CAR T Immunotherapy for Human Cancer - June, C.H., O’Connor, R.S., Kawalekar, O.U., Ghassemi, S. and Milone, M.C., 2018. CAR T cell immunotherapy for human cancer. Science, 359(6382), pp.1361-1365.
https://www.science.org/doi/10.1126/science.aar6711
[4] CAR T Limitations and Potential Strategies - Sterner, R.C. and Sterner, R.M., 2021. CAR-T cell therapy: current limitations and potential strategies. Blood cancer journal, 11(4), pp.1-11.
https://www.nature.com/articles/s41408-021-00459-7
[5] Side effects of Chemotherapy - Johnsson, A., Demmelmaier, I., Sjövall, K., Wagner, P., Olsson, H. and Tornberg, Å.B., 2019. A single exercise session improves side-effects of chemotherapy in women with breast cancer: an observational study. BMC cancer, 19(1), pp.1-9.
https://bmccancer.biomedcentral.com/articles/10.1186/s12885-019-6310-0
[6] Recent advances in Targeted Cancer Therapy - Chen, W.H., Luo, G.F. and Zhang, X.Z., 2019. Recent advances in subcellular targeted cancer therapy based on functional materials. Advanced Materials, 31(3)
https://doi.org/10.1002/adma.201802725